103 related articles for article (PubMed ID: 19681782)
1. Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs.
Metzsch C; Linnér R; Steen S; Liao Q; Algotsson L
Acta Anaesthesiol Scand; 2010 Jan; 54(1):103-10. PubMed ID: 19681782
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
[TBL] [Abstract][Full Text] [Related]
3. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2006 Jan; 50(1):99-107. PubMed ID: 16451157
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
Zhu BQ; Simonis U; Cecchini G; Zhou HZ; Li L; Teerlink JR; Karliner JS
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):119-28. PubMed ID: 16891289
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide.
Caimmi PP; Molinari C; Uberti F; Micalizzi E; Valente G; Mary DA; Vacca G; Grossini E
Eur J Cardiothorac Surg; 2011 Apr; 39(4):e59-67. PubMed ID: 21247774
[TBL] [Abstract][Full Text] [Related]
7. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R
Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242
[TBL] [Abstract][Full Text] [Related]
8. Peripheral tissue metabolism during off-pump versus on-pump coronary artery bypass graft surgery: the microdialysis study.
Pojar M; Mand'ák J; Cibícek N; Lonský V; Dominik J; Palicka V; Kubícek J
Eur J Cardiothorac Surg; 2008 May; 33(5):899-905. PubMed ID: 18328724
[TBL] [Abstract][Full Text] [Related]
9. Influence of an early adrenergic blockade on thrombotic infarct size and myocardial metabolism.
Zmudka K; Dubiel J; Pieniazek P; Dudek D; Kocurek A; Trebacz J; Grodecki J; Flameng W; de Geest H
J Physiol Pharmacol; 1998 Sep; 49(3):333-52. PubMed ID: 9789788
[TBL] [Abstract][Full Text] [Related]
10. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
[TBL] [Abstract][Full Text] [Related]
11. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
Rao Y; Wang YL; Zhang WS; Liu J
Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
[TBL] [Abstract][Full Text] [Related]
12. Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.
Shibata I; Cho S; Yoshitomi O; Ureshino H; Maekawa T; Hara T; Sumikawa K
Scand Cardiovasc J Suppl; 2013 Feb; 47(1):50-7. PubMed ID: 22994851
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
14. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
15. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
16. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury.
Arya DS; Bansal P; Ojha SK; Nandave M; Mohanty I; Gupta SK
Life Sci; 2006 May; 79(1):38-44. PubMed ID: 16457854
[TBL] [Abstract][Full Text] [Related]
18. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study.
Wu X; Wu J; Yan X; Zhang Y
Cardiology; 2014; 128(2):202-8. PubMed ID: 24751502
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S
Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
